Palladium Partners’s Novartis NVS Stock Holding History

Palladium Partners’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,866	Closed	-$203K	–	250
2016 Q3	$203K	Sell	2,866 -335	-10%	-$24.4K	0.02%	244
2016 Q2	$237K	Hold	3,201	–	–	0.02%	222
2016 Q1	$208K	Hold	3,201	–	–	0.02%	226
2015 Q4	$247K	Buy	+3,201	New	+$254K	0.02%	215
2015 Q1	–	Sell	-2,455	Closed	-$204K	–	256
2014 Q4	$204K	Sell	2,455 -71	-3%	-$5.88K	0.02%	249
2014 Q3	$213K	Buy	+2,526	New	+$204K	0.02%	240
2014 Q2	–	Sell	-3,543	Closed	-$270K	–	399
2014 Q1	$270K	Hold	3,543	–	–	0.02%	229
2013 Q4	$255K	Hold	3,543	–	–	0.02%	231
2013 Q3	$244K	Hold	3,543	–	–	0.02%	227
2013 Q2	$225K	Buy	+3,543	New	+$231K	0.02%	227

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return

Palladium Partners's NVS Position: Q4 2016 in Review

Palladium Partners sold out of Novartis (NVS) in Q4 2016, closing a stake of 2,866 shares — an estimated $203K sold.

Palladium Partners first reported a position in NVS in Q2 2013 and held it in 10 quarters. The position peaked at $270K in Q1 2014. 905 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

Palladium Partners reported no remaining Novartis position as of Q4 2016 after selling out during the quarter.
Palladium Partners sold 2,866 Novartis shares in Q4 2016, an estimated $203K.
Palladium Partners first reported a position in Novartis in Q2 2013 and held it in 10 quarters.
Palladium Partners's Novartis position peaked at $270K in Q1 2014.
905 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on Palladium Partners's 13F filing for Q4 2016, filed 1 Feb 2017.